Hemoglobin News and Research RSS Feed - Hemoglobin News and Research

AbbVie announces initiation of first Elagolix Phase 3 study in patients with uterine fibroid

AbbVie announces initiation of first Elagolix Phase 3 study in patients with uterine fibroid

AbbVie, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo. [More]
New clinical chemistry analyzer highlighted by EKF Diagnostics at Arab Health 2016

New clinical chemistry analyzer highlighted by EKF Diagnostics at Arab Health 2016

EKF Diagnostics, the global in vitro diagnostics company, will be highlighting its new Altair™ 240 clinical chemistry analyzer alongside many of its other point-of-care (POC) and laboratory diagnostics products at Arab Health 2016, Dubai, 25 - 28th January. [More]
Coordinated care approach to diabetes self-management benefits underserved adult populations

Coordinated care approach to diabetes self-management benefits underserved adult populations

Even in communities with barriers to health care, exercise opportunities and healthy food, residents with diabetes saw improved health outcomes when they participated in programs that took a coordinated care approach to diabetes self-management. [More]
“Anemia and Hemoglobin Testing” guide published by EKF Diagnostics

“Anemia and Hemoglobin Testing” guide published by EKF Diagnostics

EKF Diagnostics, the global in vitro diagnostics company, announces the publication of its new guide, “Anemia and hemoglobin testing” . [More]
Bayer to present new research findings on Xofigo (radium Ra 223 dichloride) injection at ASCO GU 2016

Bayer to present new research findings on Xofigo (radium Ra 223 dichloride) injection at ASCO GU 2016

Bayer announced today that new research findings on Xofigo (radium Ra 223 dichloride) injection will be presented at the 2016 Genitourinary Cancers Symposium of the American Society of Clinical Oncology (ASCO GU) taking place January 7 – 9 in San Francisco. [More]
UAB study to examine social support, intuitive eating impact on older African-American men with diabetes

UAB study to examine social support, intuitive eating impact on older African-American men with diabetes

University of Alabama at Birmingham School of Nursing Assistant Professor Loretta T. Lee, Ph.D., has received a 2015 Deep South Resource Center for Minority Aging pilot grant award to examine the association of social support and intuitive eating with glycemic control in older African-American men with diagnosed type 2 diabetes. [More]
Anemia associated with increased risk of mild cognitive impairment

Anemia associated with increased risk of mild cognitive impairment

In a large population-based study of randomly selected participants in Germany, researchers found that participants with anemia, defined as haemoglobin <13 g/dl in men and <12 g/dl in women, showed lower performances in verbal memory and executive functions. [More]
CytoSorbents partners with Hoang Long Pharma to bring CytoSorb to Vietnam

CytoSorbents partners with Hoang Long Pharma to bring CytoSorb to Vietnam

CytoSorbents Corporation, a leader in critical care immunotherapy commercializing its CytoSorb extracorporeal cytokine adsorber to control deadly inflammation using blood purification, today announced an exclusive multi-year distribution agreement with Hoang Long Pharma, a medical distributor in Vietnam specializing in the distribution of innovative pharmaceuticals, biologics, and devices to treat patients suffering from critical illnesses, immunologic disorders and deficiencies, and infections. [More]
Mayo Clinic researchers report national trend toward overtesting HbA1C levels in diabetes patients

Mayo Clinic researchers report national trend toward overtesting HbA1C levels in diabetes patients

In a study released online today in The BMJ, researchers from Mayo Clinic report a national trend toward overtesting glycated hemoglobin (HbA1C) levels in adult patients with Type 2 diabetes. [More]
New technology may facilitate early detection of sickle cell disease for infants in developing countries

New technology may facilitate early detection of sickle cell disease for infants in developing countries

Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings this weekend at the 57th Annual Meeting of the American Society of Hematology in Orlando. [More]
Research shows significant step toward improving outcomes, reducing treatment burden for SCD patients

Research shows significant step toward improving outcomes, reducing treatment burden for SCD patients

Emerging therapies and promising new insights in the treatment of sickle cell disease represent a significant step toward improving outcomes and reducing the treatment burden for affected children and adults. Studies reporting these advances will be presented today at the 57th American Society of Hematology Annual Meeting and Exposition. [More]
Ibrutinib more effective than traditional chemotherapy in older untreated patients with CLL

Ibrutinib more effective than traditional chemotherapy in older untreated patients with CLL

A multi-center, international, randomized, Phase III study of older untreated patients with chronic lymphocytic leukemia (CLL) demonstrated that ibrutinib, a kinase inhibitor, is significantly more effective than traditional chemotherapy with chlorambucil. [More]
Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

New research adds to a growing body of evidence that gene therapy, an experimental technique that involves correcting or replacing a person's mutated or malfunctioning genes, may improve health outcomes for patients with inherited bleeding and immune disorders as well as some forms of blood cancer. [More]
Combining two blood sugar tests may improve prediabetes detection, study finds

Combining two blood sugar tests may improve prediabetes detection, study finds

Using a combination of two blood sugar tests rather than a single test would improve detection of prediabetes in American children and adults, according to a new study by researchers at the School of Public Health at Georgia State University. [More]
Testosterone treatment can benefit men with Type 2 diabetes

Testosterone treatment can benefit men with Type 2 diabetes

Men with Type 2 diabetes who have low testosterone levels can benefit significantly from testosterone treatment. [More]
Rice University study examines variation between blood drops drawn from single fingerprick

Rice University study examines variation between blood drops drawn from single fingerprick

When it comes to needles and drawing blood, most patients agree that bigger is not better. But in the first study of its kind, Rice University bioengineers have found results from a single drop of blood are highly variable, and as many as six to nine drops must be combined to achieve consistent results. [More]
Boston Children's Hospital selects Vijay G. Sankaran to receive Rising Star Award

Boston Children's Hospital selects Vijay G. Sankaran to receive Rising Star Award

Saluting his spectacular track record to date of innovative research on red blood cell disorders and his future promise as a physician/scientist, Boston Children's Hospital has selected Vijay G. Sankaran, MD, PhD, of Dana-Farber/Boston Children's Cancer and Blood Disorders Center to receive the Rising Star Award at the hospital's third annual Global Pediatric Innovation Summit, Taking on Tomorrow (#PedInno15). [More]
New clinical chemistry analyzer launched by EKF at Medica 2015

New clinical chemistry analyzer launched by EKF at Medica 2015

EKF Diagnostics, the global in vitro diagnostics company, launched the Altair™ 240 clinical chemistry analyzer to the European market at Medica 2015, Düsseldorf, 16-19th November. [More]
Gastric balloon in a pill helps patients lose weight without surgery or endoscopy

Gastric balloon in a pill helps patients lose weight without surgery or endoscopy

A new gastric balloon that can be swallowed like a pill and then filled while in the stomach, helped patients lose more than 37 percent of their excess weight over four months, according to new research presented here at ObesityWeek 2015, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The weeklong conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS). [More]
Hand-held device makes blood draws easier, less painful

Hand-held device makes blood draws easier, less painful

Blood drawing for patients with hard-to-reach veins just became a lot easier and less painful at The Valley Hospital in Ridgewood, NJ, thanks to a small hand-held device that lights up veins like a roadmap. [More]
Advertisement
Advertisement